Medical/Pharmaceuticals

Innovent's First New Drug Application of Mazdutide for Chronic Weight Management has been Accepted by the NMPA of China

ROCKVILLE, Md. and SUZHOU, China, Feb. 7, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic...

2024-02-07 16:35 4067

MGI and ADK Trading and Shipping Forge Partnership to Bring Genomics Products to ADK Hospital in the Maldives

DUBAI, UAE, Feb. 7, 2024 /PRNewswire/ -- MGI Tech, a company committed to building core tools and technology to lead life science, today announced the signing of a sales agreement with ADK Trading and Shipping at Medlab Middle East 2024. The agreement includes the installation of mid-low throughp...

2024-02-07 14:51 1689

The Results of Phase II Clinical Study of KN046 in Combination with Nab-paclitaxel in TNBC were Published in Nature Communications

SUZHOU, China, Feb. 6, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the phase Ⅱclinical research results of anti- PD-L1/CTLA-4 bispecific antibody KN046 in combination with nab-paclitaxel as first-line treatment in advanced triple-negative breast cancer (TNBC) were ...

2024-02-07 09:50 1672

SMC Laboratories Reveals Innovative STAM™-HCC/IO+ Mouse for Identifying and Developing Novel Therapeutic Drugs for Liver Cancer, Blazing a Trail in the Immuno-Oncology Field

TOKYO, Feb. 7, 2024 /PRNewswire/ -- SMC Laboratories, Inc. ("SMC Laboratories"), a non-clinical contract research organization (CRO) that provides consulting and contract services for pharmacology studies utilizing technology and know-how related toMetabolic dysfunction associated steatohepatiti...

2024-02-07 02:00 1437

SMC Laboratories Reveals Innovative STAM™-HCC/IO+ Mouse for Identifying and Developing Novel Therapeutic Drugs for Liver Cancer, Blazing a Trail in the Immuno-Oncology Field

TOKYO, Feb. 7, 2024 /PRNewswire/ -- SMC Laboratories, Inc. ("SMC Laboratories"), a non-clinical contract research organization (CRO) that provides consulting and contract services for pharmacology studies utilizing technology and know-how related to Metabolic dysfunction associated steatohepatit...

2024-02-07 02:00 1391

ShiraTronics Completes Australian Pilot Study Enrollment; Prepares for Pivotal Clinical Study

MINNEAPOLIS, Feb. 7, 2024 /PRNewswire/ -- ShiraTronics, Inc., a pioneering clinical-stage medical device company, today proudly announced the successful conclusion of enrollment in their pilot study conducted inAustralia for their minimally invasive, implantable migraine therapy.

2024-02-06 23:12 1410

GC Labs successfully concludes day2 of Medlab Middle East 2024

YONGIN, South Korea, Feb. 6, 2024 /PRNewswire/ -- GC Labs, a leading clinical laboratory inSouth Korea, announced that the company concluded day2 with a successful performance at the Medlab Middle East 2024. An image o...

2024-02-06 23:00 1425

At AGBT, Complete Genomics showcases expanded sequencing applications, talks from customers and collaborators on research powered by the DNBSEQ-T7 Sequencer

The genomic sequencing solutions provider also introduces Q40 sequencing quality, announces new DNBSEQ products SAN JOSE, Calif., Feb. 6, 2024 /PRNewswire/ -- Complete Genomics, a California-based life sciences company that provides novel, comprehensive sequen...

2024-02-06 22:00 1153

Zuellig Pharma to Rollout the Volvo FE Electric truck for cold chain logistics

TAIPEI, Feb. 6, 2024 /PRNewswire/ -- The signing ceremony between Taikoo Motors, Zuellig Pharma, and Long Feng Medical Logistics confirmed the first delivery of a Volvo FE Electric truck for cold chain logistics inTaiwan, marking their partnership in promoting green transportation and heralding a...

2024-02-06 10:20 7572

Nordic Bioscience to make its precision medicine biomarker PRO-C3 available in China for research use only (RUO) in the first quarter of 2024.

HERLEV, Denmark, Feb. 6, 2024 /PRNewswire/ -- Nordic Bioscience, a leading biomarker company, today announced that the company's extracellular matrix (ECM) biomarker, PRO-C3 (nordicPRO-C3™) will be available as a research use only (RUO) product inChina at LabCorp. All testing outside China contin...

2024-02-06 06:30 1362

TraceLink's 2023 Success: Expanded Digitalization Capabilities and Growing Adoption of New Supply Chain Solutions

BOSTON, Feb. 6, 2024 /PRNewswire/ -- TraceLink, the world's largest digital network platform for healthcare and life sciences, expanded its digitalization capabilities in 2023, leading to an annual increase of more than 300 new customers. Utilizing the industry's largest integrated digital networ...

2024-02-06 04:50 1222

Rokit Healthcare Scores High Marks in KOSDAQ Tech Listing Evaluation

SEOUL, South Korea, Feb. 5, 2024 /PRNewswire/ -- Rokit Healthcare, a trailblazer in AI-driven medical bioprinting technology, proudly announces its achievement of an AA rating in the KOSDAQ (Korea Securities Dealers Automated Quotations) technology listing evaluation. Garnering A grades from both...

2024-02-05 22:00 1300

Genesis MedTech Completes Enrollment in its United States Early Feasibility Study Utilizing the J-Valve™ Transfemoral System for Patients with Severe Aortic Regurgitation

JC Medical reports milestone accomplishment with its TAVR device BURLINGAME, Calif., Feb. 5, 2024 /PRNewswire/ -- Genesis MedTech, a leading medical device company, today announced the completion of enrollment in its United States Early Feasibility Study (EFS) using its dedicated transcatheter ...

2024-02-05 22:00 1146

BrainGear Develops SleePYA, the Digital Healthcare for Brain Rehabilitation and Sleep Aid

SEOUL, South Korea, Feb. 5, 2024 /PRNewswire/ -- As startup engaging in digital healthcare business, especially brain rehabilitation and sleep aid, BrainGear has developed SleePYA with infrared light to stimulate the brain to induce quality of sleep.

2024-02-05 22:00 1223

Technoderma Medicines Phase 2 Clinical Trial of TDM-105795 Demonstrates Hair Growth in Androgenetic Alopecia

CHENGDU, China, Feb. 5, 2024 /PRNewswire/ -- Technoderma Medicines, Inc. ("the Company"), a clinical stage biopharmaceutical company, is pleased to report that the Company has completed its Phase 2a clinical trial (NCT05802173) of TDM-105795 topical solution for Androgenetic Alopecia (AGA). This ...

2024-02-05 21:00 1312

NouvNeu001 Achieves Milestone with Successful Dosing of First Patient, Signaling Smooth Progress in iRegene Therapeutics' Multicenter Clinical Trial for Innovative Novel Parkinson's Disease Therapy

WUHAN, China, Feb. 5, 2024 /PRNewswire/ -- iRegene Therapeutics Co., Ltd (iRegene) recently announced that NouvNeu001, the company's first innovative product, has completed the dosing for its first patient at Beijing Hospital, and the patient has also successfully concluded the observation period...

2024-02-05 21:00 1407

Venus Medtech VenusP-Valve transcatheter pulmonic valve replacement system granted Health Canada approval

HANGZHOU, China, Feb. 5, 2024 /PRNewswire/ -- Venus Medtech (02500. HK), a leading provider of integrated solutions for transcatheter structural heart valvular therapies inChina, announced today that, VenusP-Valve, the company's in-house developed innovative transcatheter pulmonic valve replaceme...

2024-02-05 21:00 1645

Personnel changes in the Exyte management: Mark Garvey and Elena Bashkeeva are welcomed as new members of the Executive Board

* High-tech industry expert Mark Garvey is new Segment CEO for Exyte's Global Business Unit Advanced Technology Facilities * Elena Bashkeeva will become CFO at Exyte starting April 1st 2024 and will lead the Finance and Controlling functions as well as IT STUTTGART, Germany, Feb. 5, 2024 /PRN...

2024-02-05 20:00 1386

Luye Pharma Grants Myung In Pharm Exclusive Rights to Commercialize Rivastigmine Twice Weekly Transdermal Patch in South Korea

YANTAI, China, Feb. 5, 2024 /PRNewswire/ -- Luye Pharma Group has entered into an agreement with Myung In Pharm, granting the latter the exclusive rights to commercialize Rivastigmine Twice Weekly Transdermal Patch inSouth Korea. Developed by Luye Pharma, this drug is used to treat mild to modera...

2024-02-05 18:53 1694

CARiNG Pharmacy Awarded Gold in Esteemed Putra Aria Brand Awards 2023 in Retail Category

KUALA LUMPUR, Malaysia, Feb. 5, 2024 /PRNewswire/ -- CARiNG Pharmacy proudly announced its victory at the second edition of the prestigious Putra Aria Brand Awards 2023, securing the coveted Gold Award in the Retail Category in recognition of its outstanding contributions to the retail industry. ...

2024-02-05 17:31 1257
1 ... 22232425262728 ... 576